Mount Sinai BioDesign expands collaboration with MedTech community to enhance medical innovation

Mount Sinai Health System today announced that Mount Sinai BioDesign, the medical technology incubator of the Health System, has expanded its reach to become a key, effective partner for the broader MedTech community.

New approach for cervical cancer vaccines based on microsphere-encapsulated peptides

Infection with HPV16, a high-risk human papillomavirus (HPV), can cause cervical cancer in humans. These infections carry a high risk of morbidity and mortality globally

October 29, 2024

H1 2024 RESULTS – Major advances in all three programs – Several strategic agreements signed with the world medtech leader in cardiology – Extension of financial runway – Biotech Investments

EQS-News: Affluent Medical SA / Key word(s): Half Year Results Affluent Medical SA: H1 2024 RESULTS – Major advances in all three programs – Several

September 27, 2024

Study identifies hormonal and reproductive factors for rheumatoid arthritis in women

Early menopause-;before the age of 45-;taking hormone replacement therapy (HRT), and having 4 or more children are among several hormonal and reproductive factors linked to

January 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.